Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Fixed Capital/Sales

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.420.480.360.360.55

What is the latest Fixed Capital/Sales ratio of NGL FINECHEM ?

The latest Fixed Capital/Sales ratio of NGL FINECHEM is 0.42 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.42
Mar20230.48
Mar20220.36
Mar20210.36
Mar20200.55

How is Fixed Capital/Sales of NGL FINECHEM Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.42
-12.50
Mar2023 0.48
33.33
Mar2022 0.36
0.00
Mar2021 0.36
-34.55
Mar2020 0.55 -

Other Financial Ratios of NGL FINECHEM


Compare Fixed Capital/Sales ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹654.0 Cr -2.3% -8.9% -52.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,394.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-2.3%

-8.9%

-52.7%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses